Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Use this OGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Organon & Co even when a live quote feed is slow.
Latest cached year on this hub. Full OGN income, balance, and cash tables.